Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

The query: title or abstract mentions "smoking", "smoker", "cigarette", "tobacco" or "nicotine", matched case-insensitively against each record's title and abstract (its summary field) in alzhub's library of 29,780 study records, as of 2026-11-09. Every count on this page comes from that match. The matched list as JSON.

Smoking damages blood vessels throughout the body including the brain, promotes inflammation and oxidative stress, and is tied to stroke and heart disease, all of which feed into dementia risk. Older studies sometimes suggested nicotine might protect against Alzheimer's; later work attributed that to smokers dying younger, before the age at which dementia is common. The research now asks how much risk falls after quitting, and how quickly.

This page describes what published research in alzhub's library reports. It is not medical advice and does not apply to any one person: a doctor who knows the person's history is the only one who can say what a result or a treatment means for them.

What the studies report, in their own words

Whole sentences copied from the abstract or key findings of the highest-scoring matched studies, chosen because they mention the subject and give a figure. 8 of the 475 matched records are quoted; each links to its study page and from there to the paper.

“Approximately 30%-40% of dementia cases have been estimated to be attributed to modifiable risk factors, including hypertension, smoking and sedentary lifestyle.”
From the abstract of Prevention of dementia using mobile phone applications (PRODEMOS): protocol for an international randomised controlled trial · BMJ open · 2021 · randomized controlled trial ·
“Overall, 28·8 million (95% UI 24·5-34·0) DALYs were attributed to dementia; 6·4 million (95% UI 3·4-10·5) of these could be attributed to the modifiable GBD risk factors of high BMI, high fasting plasma glucose, smoking, and a high intake of sugar-sweetened beverages.”
From the abstract of Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 · The Lancet. Neurology · 2019 · systematic review ·
“Importance Previous estimates suggested that 1 in 3 cases of Alzheimer disease and related dementia (ADRDs) in the US are associated with modifiable risk factors, the most prominent being physical inactivity, depression, and smoking.”
From the key findings of Risk Factors Associated With Alzheimer Disease and Related Dementias by Sex and Race and Ethnicity in the US · JAMA neurology · 2022 · meta-analysis ·
“Meta-analysis of 31 studies with incident AD yielded pooled RR for low education (RR = 1.99; 95% CI: 1.30-3.04), high Hcy (RR = 1.93; 95% CI: 1.50-2.49), and current/ever smoking status (RR = 1.37; 95% CI: 1.23-1.52) while indicating protective effects of higher physical activity and n-3 fatty acids.”
From the abstract of Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis · BMC public health · 2014 · systematic review ·
“Results We included 207 studies and found high or moderate certainty that the following 49 variables provide valuable prognostic information on mortality and/or severe disease in patients with COVID-19 infectious disease: Demographic factors (age, male sex, smoking), patient history factors (comorbi”
From the key findings of Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review · PloS one · 2020 · systematic review ·
“In Cox proportional hazards models adjusted for education, smoking status, presence of at least one APOE epsilon4 allele, and history of stroke or diabetes at baseline, persons who had used statins were about half as likely as those who did not use statins to develop dementia/CIND (HR = 0.52; 95% CI 0.34, 0.80).”
From the abstract of Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study · Neurology · 2008 · cohort study ·
“Results We report significant associations between age acceleration and body mass index, total cholesterol to high-density lipoprotein cholesterol ratios, socioeconomic status, high blood pressure, and smoking behavior (Bonferroni-adjusted P < .05).”
From the key findings of Investigating the relationship between DNA methylation age acceleration and risk factors for Alzheimer's disease · Alzheimer's & dementia (Amsterdam, Netherlands) · 2018 · longitudinal study ·
“Among current smokers, this relationship was most pronounced (RRs, 0.65 [95% CI, 0.37-1.14] and 0.58 [95% CI, 0.30-1.12], respectively) and also was present for intake of beta carotene (RR, 0.49 [95% CI, 0.27-0.92]) and flavonoids (RR, 0.54 [95% CI, 0.31-0.96]).”
From the abstract of Dietary intake of antioxidants and risk of Alzheimer disease · JAMA · 2002 · cohort study ·

What kind of evidence it is

By study design

Design (as recorded)Studies
Systematic review or meta-analysis37
Randomised controlled trial7
Other clinical trial3
Cohort or longitudinal study89
Case-control study17
Cross-sectional study35
Other recorded design4
No design recorded283

The design is the one named in alzhub's record for the study; a record with none is counted as "no design recorded".

By year

YearStudiesShare
202624
202588
202414
202319
202220
202134
202018
201921
201815
201717
2016 and earlier205

Other counts within the matched set

Peer-reviewed articles459
Marked open access in the record184
Rated "high" evidence strength in alzhub's summary70
Rated "moderate" evidence strength in alzhub's summary158
Rated "low" evidence strength in alzhub's summary244
No evidence-strength rating3
Records stating a participant count213
Median participants (those records)1,686
Largest participant count3,142,673

Within the 475 matched studies

Studies…CountRule
…that mention quitting or former smokers32the abstract also contains "quit", "cessation", "former smoker" or "ex-smoker"
…about midlife smoking73the abstract also contains "midlife" or "middle age"
…that report a hazard ratio63the abstract also contains "hazard ratio" or "HR"

The 10 highest-scoring matched studies

Title matches first, then by alzhub's usefulness score, which rates a study's design, journal, evidence and recency, not whether its result is good news.

  1. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies American journal of epidemiology · 2007 · meta-analysis · 26,374 participants · · Peer-reviewed
  2. Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study Lancet (London, England) · 1998 · case-control study · 6,870 participants · · Peer-reviewed
  3. Relation between smoking and risk of dementia and Alzheimer disease: the Rotterdam Study Neurology · 2007 · cohort study · 6,868 participants · · Peer-reviewed
  4. Smoking and increased Alzheimer's disease risk: a review of potential mechanisms Alzheimer's & dementia : the journal of the Alzheimer's Association · 2014 · systematic review · · Peer-reviewed
  5. Cigarette Smoking is a Risk Factor for Alzheimer's Disease: An Analysis Controlling for Tobacco Industry Affiliation Journal of Alzheimer s Disease · 2010 · meta-analysis · · Peer-reviewed
  6. Smoking is associated with an increased risk of dementia: a meta-analysis of prospective cohort studies with investigation of potential effect modifiers PloS one · 2015 · · Peer-reviewed
  7. Smoking Cessation, Weight Change, and Risk of Dementia: A Prospective Cohort Study Neurology · 2026 · cohort · 32,802 participants · · Peer-reviewed
  8. Effect of smoking on global cognitive function in nondemented elderly Neurology · 2004 · case-control study · 17,610 participants · · Peer-reviewed
  9. Relationship of Cigarette Smoking and Time of Quitting with Incident Dementia and Cognitive Decline Journal of the American Geriatrics Society · 2020 · cohort study · 1,347 participants · · Peer-reviewed
  10. The effect of alcohol and tobacco consumption, and apolipoprotein E genotype, on the age of onset in Alzheimer's disease International journal of geriatric psychiatry · 2010 · cross-sectional · 397 participants · · Peer-reviewed

Systematic reviews and meta-analyses in the set

37 of the matched records are recorded as a systematic review, meta-analysis or umbrella review; the highest-scoring not already listed above:

Newest matched studies

Journals with the most matched studies

JournalStudies
Neurology33
Journal of Alzheimer's disease : JAD20
Alzheimer's & dementia : the journal of the Alzheimer's Association12
Stroke11
Alzheimer s & Dementia10

Questions

Does quitting smoking lower dementia risk?
Cohort studies that follow people after they quit generally find risk falling towards that of never-smokers over years. The quoted papers give the figures and the follow-up times behind them.
How many studies on smoking and dementia does alzhub hold?
475 of the 29,780 study records in alzhub's library match the query "title or abstract mentions "smoking", "smoker", "cigarette", "tobacco" or "nicotine""; 29 of them name it in the title. Counted from the records when this page was built.
What kinds of study are they?
37 systematic review or meta-analysis, 7 randomised controlled trials, 3 other clinical trials, 89 cohort or longitudinal studys, 17 case-control studys, 35 cross-sectional studys; 283 record no design.
What is the most recent study in the set?
"Retinal biomarkers and dementia risk: A review of evidence across the 14 Lancet modifiable risk factors for dementia" (PsyArXiv, 2026), the newest by publication date among the matched records.
Which journals publish most on it?
Neurology (33); Journal of Alzheimer's disease : JAD (20); Alzheimer's & dementia : the journal of the Alzheimer's Association (12), counted across the matched records.

Read on

Library subjects these studies are filed under

All answer pages →